[HTML] frontiersin.org

[HTML][HTML] Vildagliptin reduces stenosis of injured carotid artery in diabetic mouse through inhibiting vascular smooth muscle cell proliferation via ER stress/NF-κB …

Y Ji, Y Ge, X Xu, S Ye, Y Fan, J Zhang, L Mei… - Frontiers in …, 2019 - frontiersin.org
Dipeptidyl peptidase-4 (DPP-4) inhibitors are novel anti-hyperglycemic drugs for type 2
diabetes. It has been reported that DDP-4 inhibitor could exert pleiotropic effects on …
被引用次数：14 相关文章

Vildagliptin Reduces Stenosis of Injured Carotid Artery in Diabetic Mouse Through Inhibiting Vascular Smooth Muscle Cell Proliferation via ER Stress/NF-κB Pathway.

Y Ji, Y Ge, X Xu, S Ye, Y Fan, J Zhang, L Mei… - Frontiers in …, 2019 - europepmc.org
Abstract Dipeptidyl peptidase-4 (DPP-4) inhibitors are novel anti-hyperglycemic drugs for
type 2 diabetes. It has been reported that DDP-4 inhibitor could exert pleiotropic effects on …
[HTML] nih.gov

[HTML][HTML] Vildagliptin Reduces Stenosis of Injured Carotid Artery in Diabetic Mouse Through Inhibiting Vascular Smooth Muscle Cell Proliferation via ER Stress/NF-κB …

Y Ji, Y Ge, X Xu, S Ye, Y Fan, J Zhang… - Frontiers in …, 2019 - ncbi.nlm.nih.gov
Abstract Dipeptidyl peptidase-4 (DPP-4) inhibitors are novel anti-hyperglycemic drugs for
type 2 diabetes. It has been reported that DDP-4 inhibitor could exert pleiotropic effects on …

Vildagliptin Reduces Stenosis of Injured Carotid Artery in Diabetic Mouse Through Inhibiting Vascular Smooth Muscle Cell Proliferation via ER Stress/NF-κB Pathway

Y Ji, Y Ge, X Xu, S Ye, Y Fan… - Frontiers in …, 2019 - pubmed.ncbi.nlm.nih.gov
Dipeptidyl peptidase-4 (DPP-4) inhibitors are novel anti-hyperglycemic drugs for type 2
diabetes. It has been reported that DDP-4 inhibitor could exert pleiotropic effects on …